Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 1.65 | 20.18 |
| PEG Ratio (TTM) | -0.02 | -10.19 |
| P/S Ratio (TTM) | 1.35 | 2.89 |
| P/B Ratio (TTM) | 0.07 | 7.32 |
| P/FCF Ratio (TTM) | -4.39 | 29.41 |
| Price to 5YR AVG Earnings Ratio | 0.00 | 11.13 |
| Price to 5YR AVG FCF Ratio | 0.02 | 19.27 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.81% | 7.90% |
| ROE (TTM) | 6.08% | 44.70% |
| Net Profit Margin (TTM) | 5.02% | 12.92% |
| ROIC 5YR AVG | -3.30% | 19.02% |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 26.03% | -258.80% | -106.82% |
| Revenue | 80.08% | 64.39% | 176.41% |
| Net Income | 50.79% | -51.71% | 29.25% |
| Cash Flow | 8.03% | 81.21% | 53.96% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.08 | 1.60 |
| Quick Ratio (TTM) | 0.80 | 1.18 |
| D/E Ratio (TTM) | 1.37 | 1.79 |
| Interest Coverage (TTM) | 5.44 | 3.45 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 0.04 | 3.50 |
| LTL to 5YR AVG FCF | 4.45 | 3.97 |
| Shares Outstanding Growth 5YR AVG | 1.04% | -1.09% |